Palbociclib and Endocrine Therapy for LObular Breast Cancer Preoperative Study (PELOPS)

NCT02764541 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

195

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Letrozole
DRUG: Tamoxifen
DRUG: Palbociclib
DRUG: Endocrine Therapy

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]